Medical isotope developer IsoRay Medical of Richland, WA, saw a dip in revenue for its fiscal 2009 results, which the company attributed to challenges in the global market.
For the period (end-June 30), revenue decreased 24% to $5.4 million, compared with $7.1 million in fiscal 2008. The net loss for fiscal 2009 decreased 28% to $6.2 million, compared with a net loss of $8.5 million in the previous fiscal year, IsoRay said.
Related Reading
IsoRay nets FDA OK on seeds, August 18, 2009
IsoRay sales drop, loss narrows, May 18, 2009
IsoRay expands into Canadian market, May 7, 2009
IsoRay, BrachySciences ink deal, February 18, 2009
IsoRay sales slip in fiscal Q2, February 17, 2009
Copyright © 2009 AuntMinnie.com
